Effect of probiotic supplementation in stage 5 chronic kidney disease
Not Applicable
- Conditions
- Health Condition 1: N185- Chronic kidney disease, stage 5
- Registration Number
- CTRI/2019/12/022307
- Lead Sponsor
- Department of nephrology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Stage 5 CKD patients
Exclusion Criteria
Patients on renal replacement therapy
Serum K > 5.5 mEq/L
1.Uremic encephalopathy
2.Uremic pericarditis
3.Fluid overload despite optimal diuretic therapy
4.Patients awaiting kidney transplant
5.Planned for dialysis within 2 weeks (elective initiation of dialysis)
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method MEAN CHANGE IN BLOOD LEVELS OF UREMIC TOXINSTimepoint: 3 months
- Secondary Outcome Measures
Name Time Method Estimated GFRTimepoint: Monthly;Hb levelTimepoint: Monthly;Markers of bone metabolism- serum calcium, phosphorus,PTH levelsTimepoint: 3 months;Quality of lifeTimepoint: 3months